Tracing the future of medicine

We mark molecules with Carbon-11 to improve PET image diagnosis and to do biological traceability studies of new drugs.

We mark molecules with Carbon-11 to improve PET image diagnosis and to do biological traceability studies of new drugs

Better diagnostic

Carbon-11 opens access to the application of radiotracers for better diagnosis and treatment of oncological, neurological and cardiovascular diseases.

Radiological security

The automation and manufacture of radiotracers in single-dose format makes it possible to reduce the rates of radiation received by the patient.

Chemical compatibility

The great capacity of marking molecules with Carbon-11 makes it ideal for pharmacodynamic studies of new medicines and in research projects.

Why Cyclomed

"We commercialize and supply with carbon-11 marked radiopharmaceuticals for compassionate use in hospitals. "
Carlos Langeber
Chief Business Development Officer

Production

We have a superconducting compact cyclotron with which to produce Carbon-11.

Labeling

The Carbon-11 we produce is used to mark molecules and synthesize radiopharmaceuticals.

Analysis & studies

We analyze and study pharmacodynamics for preclinical research and development.

Supply

We commercialize and supply carbon-11 marked radiopharmaceuticals for compassionate use in hospitals.

Our team

Jose Manuel Pérez

CEO

Carlos langeber

CBDO

Isabel pérez

Project Manager Intern

lUIS GARCÍA-TAbARES

Scientific & Technical Advisor

FRANCISCO GARCÍA

Strategic Advisor

MARC RAMIS

Strategic Advisor

Partners

ciemat
antec

Contact

+34 677 124 070

Antonio Cavero 93 St., Madrid, 28043

cyclomed@cyclomed.tech